BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33597881)

  • 21. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.
    Wood JC; Magera MJ; Rinaldo P; Seashore MR; Strauss AW; Friedman A
    Pediatrics; 2001 Jul; 108(1):E19. PubMed ID: 11433098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia.
    Sasaki K; Makiyama T; Yoshida Y; Wuriyanghai Y; Kamakura T; Nishiuchi S; Hayano M; Harita T; Yamamoto Y; Kohjitani H; Hirose S; Chen J; Kawamura M; Ohno S; Itoh H; Takeuchi A; Matsuoka S; Miura M; Sumitomo N; Horie M; Yamanaka S; Kimura T
    PLoS One; 2016; 11(10):e0164795. PubMed ID: 27764147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Switch From Fetal to Adult
    Veerman CC; Mengarelli I; Lodder EM; Kosmidis G; Bellin M; Zhang M; Dittmann S; Guan K; Wilde AAM; Schulze-Bahr E; Greber B; Bezzina CR; Verkerk AO
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28739862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnostic challenge in very-long chain acyl-CoA dehydrogenase deficiency (VLCADD).
    Hesse J; Braun C; Behringer S; Matysiak U; Spiekerkoetter U; Tucci S
    J Inherit Metab Dis; 2018 Nov; 41(6):1169-1178. PubMed ID: 30194637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial very long chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant death: improved survival by prompt diagnosis.
    Scalais E; Bottu J; Wanders RJ; Ferdinandusse S; Waterham HR; De Meirleir L
    Am J Med Genet A; 2015 Jan; 167A(1):211-4. PubMed ID: 25338548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: High Incidence of Detected Patients With Expanded Newborn Screening Program.
    Remec ZI; Groselj U; Drole Torkar A; Zerjav Tansek M; Cuk V; Perko D; Ulaga B; Lipovec N; Debeljak M; Kovac J; Battelino T; Repic Lampret B
    Front Genet; 2021; 12():648493. PubMed ID: 33986768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
    Chalmers RA; Roe CR; Stacey TE; Hoppel CL
    Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
    Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
    Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lethal Undiagnosed Very Long-Chain Acyl-CoA Dehydrogenase Deficiency with Mild C14-Acylcarnitine Abnormalities on Newborn Screening.
    Spiekerkoetter U; Mueller M; Sturm M; Hofmann M; Schneider DT
    JIMD Rep; 2012; 6():113-5. PubMed ID: 23430948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevations of C14:1 and C14:2 Plasma Acylcarnitines in Fasted Children: A Diagnostic Dilemma.
    Burrage LC; Miller MJ; Wong LJ; Kennedy AD; Sutton VR; Sun Q; Elsea SH; Graham BH
    J Pediatr; 2016 Feb; 169():208-13.e2. PubMed ID: 26602010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case Report on: Very Early Afterdepolarizations in HiPSC-Cardiomyocytes-An Artifact by Big Conductance Calcium Activated Potassium Current (I
    Horváth A; Christ T; Koivumäki JT; Prondzynski M; Zech ATL; Spohn M; Saleem U; Mannhardt I; Ulmer B; Girdauskas E; Meyer C; Hansen A; Eschenhagen T; Lemoine MD
    Cells; 2020 Jan; 9(1):. PubMed ID: 31968557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
    Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
    Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human Induced Pluripotent Stem Cell-Derived Non-Cardiomyocytes Modulate Cardiac Electrophysiological Maturation Through Connexin 43-Mediated Cell-Cell Interactions.
    Biendarra-Tiegs SM; Clemens DJ; Secreto FJ; Nelson TJ
    Stem Cells Dev; 2020 Jan; 29(2):75-89. PubMed ID: 31744402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.
    Cox KB; Hamm DA; Millington DS; Matern D; Vockley J; Rinaldo P; Pinkert CA; Rhead WJ; Lindsey JR; Wood PA
    Hum Mol Genet; 2001 Sep; 10(19):2069-77. PubMed ID: 11590124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening.
    Merritt JL; Vedal S; Abdenur JE; Au SM; Barshop BA; Feuchtbaum L; Harding CO; Hermerath C; Lorey F; Sesser DE; Thompson JD; Yu A
    Mol Genet Metab; 2014 Apr; 111(4):484-92. PubMed ID: 24503138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and biochemical outcome of patients with very long-chain acyl-CoA dehydrogenase deficiency.
    Rovelli V; Manzoni F; Viau K; Pasquali M; Longo N
    Mol Genet Metab; 2019 May; 127(1):64-73. PubMed ID: 31031081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medium-chain triglycerides impair lipid metabolism and induce hepatic steatosis in very long-chain acyl-CoA dehydrogenase (VLCAD)-deficient mice.
    Tucci S; Primassin S; Ter Veld F; Spiekerkoetter U
    Mol Genet Metab; 2010 Sep; 101(1):40-7. PubMed ID: 20580297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carnitine palmitoyltransferase 2: New insights on the substrate specificity and implications for acylcarnitine profiling.
    Violante S; Ijlst L; van Lenthe H; de Almeida IT; Wanders RJ; Ventura FV
    Biochim Biophys Acta; 2010 Sep; 1802(9):728-32. PubMed ID: 20538056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation.
    Kler RS; Jackson S; Bartlett K; Bindoff LA; Eaton S; Pourfarzam M; Frerman FE; Goodman SI; Watmough NJ; Turnbull DM
    J Biol Chem; 1991 Dec; 266(34):22932-8. PubMed ID: 1744086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.